Obesity may send a damaging fat signal to the brain, Alzheimer's mouse study finds

A class of fat molecules called phosphatidylethanolamines rises with obesity, gets packaged into carrier particles, and reaches the brain, where, in Alzheimer's mouse models, it disrupts immune defenses and encourages amyloid, the protein buildup long associated with the disease.

That pathway is the central finding from a Houston Methodist–led study published July 30 in Molecular Neurodegeneration. Co-led by biomedical engineer Stephen Wong and research associate Li Yang, the work traces a specific lipid messenger from peripheral fat into the brain and shows that rebalancing it in mice bred to model Alzheimer's can preserve memory.

The team combined quantitative lipidomics, single-nucleus RNA sequencing, proteomics, and high-resolution imaging to map how obesity-driven PE excess travels in carrier particles, crosses into the brain, weakens microglial protection, and amplifies amyloid accumulation. Restoring a healthier PE mix improved both brain function and memory on behavioral tests.

Wong called the work a direction for future treatments: obesity "can change how signals travel to the brain," he said in the Houston Methodist release, and researchers "may be able to target the process that connects those changes to the brain." The paper itself is more cautious: a single preclinical study from one institution, and lipid-rewiring candidates have a long record of failing in human trials. The team does not claim obesity causes Alzheimer's, only that elevated PEs, in models, can help carry the damage there.

The original paper is at Molecular Neurodegeneration, with corroborating coverage on Medical Xpress.